Your browser doesn't support javascript.
loading
Nuclear pCHK1 as a potential biomarker of increased sensitivity to ATR inhibition.
Sundararajan, Vignesh; Tan, Tuan Zea; Lim, Diana; Peng, Yanfen; Wengner, Antje Margret; Ngoi, Natalie Yan Li; Jeyasekharan, Anand D; Tan, David Shao Peng.
Afiliação
  • Sundararajan V; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Lim D; Genomics and Data Analytics Core (GeDaC), Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Peng Y; Department of Pathology, National University Hospital, Singapore, Singapore.
  • Wengner AM; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Ngoi NYL; Bayer AG, Pharmaceuticals, Berlin, Germany.
  • Jeyasekharan AD; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Tan DSP; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
J Pathol ; 259(2): 194-204, 2023 02.
Article em En | MEDLINE | ID: mdl-36373784
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dano ao DNA / Inibidores de Proteínas Quinases Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dano ao DNA / Inibidores de Proteínas Quinases Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article